1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Characteristics and results of the cases with astrocytoma, IDH-mutant, CNS WHO grades 2–4
Case Age (yr) Subgroup Fusion/Methylation Analysis T2-FLAIR Mismatch Sign (S) or Area (A) Histology Microcysts Enlarged Intercellular Spaces 12 17.7 IDH +, WHO 2 IDH (R132H), ATRX, TP53 + (A) + + 13 9.2 IDH +, WHO 2 IDH (R132H), TP53 – + + 14 18.7 IDH +, WHO 2 IDH (R132H), ATRX, TP53 + (S) – + 15 14.0 IDH +, WHO 2 IDH (R132H), ATRX, TP53 – + + 16 10.6 IDH +, WHO 2 IDH (R132H), TP53 – – + 17 4.0 IDH +, WHO 2 IDH (R132H), PIK3CA, NF1 – + – 18 17.1 IDH +, WHO 3 IDH (R132H), PTEN, TP53 – + + 19 15.6 IDH +, WHO 4 IDH (R132H), TP53, MSH6, ATRX, CDKN2A, CIC. –
Note:—The + indicates presence; −, absence of the characteristic.